Bangladesh's ACA2 Eye Care Recognized by Moorfields Hospital for Advancing AI with RETFound

Read Full Story
Shapes
Hero Banner

Cure to blindness knows no borders nor our vision

Shapes
0

Total Guests Served

0

Total Fundus image processed

0+

Total Cataract Operated

0+

Total Major Disease Detected

Our Mission

Amar Chokh Amar Alo (ACA2) is a community-led, AI-assisted network of low-cost eye clinics built with Data Yakka’s digital ophthalmology technology.

These clinics bring sight-saving care to some of the most remote coastal communities in Bangladesh, places with no doctors, no clinics, and, in some cases, no electricity.

In ACA2 clinics, every person is seen with care and dignity. From the moment they arrive, they receive health check-ups, vision tests, and, when needed, advanced retinal imaging. 

AI analyses the images instantly. Urgent cases are reviewed in real time by specialists thousands of miles away.

Every step is recorded in a paperless, web-based platform that manages patient flow, follow-ups, and referrals from islands to regional tertiary hospitals.

Hasib Rahman
Hasib Rahman

VP, Data and Artificial Intelligence

Mission Banner

Who We Are

We’re a small team of AI engineers, clinical innovators, and community-mobilisation architects.

We build practical, clinically robust, low-cost, AI-enabled eye-care platforms for remote and isolated regions with zero infrastructure.

We work closely with Stanford University’s Dr. Randall Stafford and Dr. Robert Chang, along with Prof. Pearse Keane of Moorfields Eye Hospital and UCL, globally recognised pioneers in public health, digital ophthalmology, and AI-driven eye-disease diagnosis.

Dr. Randall S. Stafford, MD, PhD
Dr. Randall S. Stafford, MD, PhD

Professor of Medicine, Stanford School of Medicine

Who We Are Banner

Our Impacts Are Global

Through our initiatives, Stop Blindness has restored sight to thousands of individuals across remote and coastal communities.

Impact Map
People Icon

Total Patients Served

51103
Male Icon

Percentage of Male Patients

41.38%
Female Icon

Percentage of Female Patients

58.59%